Introduction
Spectrins are key proteins involved in the support of general membrane integrity, stabilization of cell -cell interactions, axonal growth, normal functioning of the Golgi complex as well as organization of synaptic vesicles (Nelson and Veshnock, 1987a; Nelson and Hammerton, 1989; Bennett and Gilligan, 1993; Lux and Palek, 1995; Morrow et al., 1997; Pinder and Baines, 2000; De Matteis and Morrow, 2000) .
Spectrin is a tetrameric actin crosslinking protein consisting of two alpha and two beta subunits. Two genes for a-spectrin (Goodman et al., 1995; ; for review see Morrow et al., 1997; Ziemnicka-Kotula et al., 1998) and five for b-spectrin have been identified to date in both mice and humans, each of which is alternatively spliced to produce multiple spectrin isoforms (Bennett et al., 1982; Birkenmeier et al., 1988; Gallagher and Forget, 1993; Goodman et al., 1995) . The expression of isoforms is regulated in a complex, tissue-and time-specific manner in a variety of cells. b-spectrin is more diverse than a-spectrin and currently includes at least 12 members that can be placed in nine general categories: (1) A mammalian erythrocytic b-spectrin (bSpIS1 or b-R , 246 kD) (Winkelman et al., 1988; Bloom et al., 1993) ; (2) An isoform of b-R with a different Cterminal sequence due to alternate exon usage (bSpIS2, 270 kD) (Malchiodi-Albedi et al., 1993) ; (3) Nonerythroid b-spectrin or Fodrin (bSpIIS1 or b-G) which is the general form of b-spectrin expressed in multiple tissue (Zimmer et al., 1991; Hu et al., 1992) as well as a brain specific isoform Ma et al., 1993) ; (4) Recently identified novel b-G spectrin, lacking the C-terminal pleckstrin homology (PH) domain ELF 1, 2, 3, 4 (Mishra et al., 1998 Hayes et al., 2000) ; (5) The newly cloned b-spectrin III, SPTBN2, (Ohara et al., 1998) , a Golgi-associated spectrin (Stankewich et al., 1998) that has a restricted tissue expression and is most highly expressed in the brain, staining dendrites more strongly than cell bodies (Ohara et al., 1998) , also possibly linked to the isoform that interacts with Munc 13 (Sakaguchi et al., 1998) ; (6) A 430 kD b-spectrin (b-IV) isoform identified in Drosophila (b-H ) (Goodman et al., 1995; Thomas and Kiehart, 1994; Zarnescu and Thomas, 1999) ; (7) b-V spectrin that associates with photoreceptor discs of the outer segment of the retina (Stabach and ; (8) A neuromuscular junction b-spectrin isoform (b-NM ) (Bloch and Morrow, 1989 ) and (9) b TW , a specialized form localized to the terminal web of intestinal epithelial cells in birds (Glenney et al., 1983) .
Although spectrin levels have been noted to be raised after gastrulation, at a time when cell differentiation is a prominent feature (Moon and McMahon, 1987) , the roles of specific b-spectrin subunits such as ELF in the developing nervous system have not been identified to date. We have cloned a group of novel differentially expressed b-spectrins, elf 1-3 (Mishra et al., 1998 that are different from the mouse brain and main b-G spectrin isoform in that they have unique N-and Cterminal domains marked by an absence of a Cterminal PH domain. To gain additional insight into the structure and function of elf-3 and to determine its role in neural development we cloned the chromosomal gene encoding elf-3, analysed its genomic structure as well as its expression in mid-embryonic central nervous system development. In this study we demonstrate the genomic structure of elf-3, spanning a 67 kb region, and that elf is probably an alternatively spliced isoform of b-G spectrin, with distinct N-and C-termini. Several lines of evidence indicate that ELF is a novel b-spectrin and not an isoform of b-G spectrin. The most crucial evidence comes from the null-mutant of elf, which shows absence of the corresponding genomic DNA, messenger RNA and protein in all tissues (manuscript in preparation). We also identify specific neuronal precursors and neurons that express ELF utilizing antibodies to domains unique to ELF isoforms.
Results

Genomic organization of mouse ELF
By screening 1610 6 recombinants of Lambda FIX II mouse genomic libraries, as well as two BAC libraries with Z-2 cDNA probe , we isolated 12 mouse genomic clones with one clone (named as G1) containing an approximately 15-kb insert, and two BAC clones. The G1 genomic clone was digested with NotI and subcloned into the SK Bluescript vector. At the same time two BAC clones were isolated and sequenced. The results showed that the nucleotide sequence derived from G1 DNA, as well as three contiguous stretches of DNA from the two BAC clones was identical to the elf cDNA sequence derived from embryonic liver (subtractive hybridization cDNA library) or adult liver mRNA (Marathon cDNA library). A total of 67 kb elf genomic DNA sequence was obtained. Within a 15 kb region of 3' end, further homologous sequences to spectrin genes were found. Both sequence analysis and restriction enzyme maping indicate that elf is a 31 exon gene (Table  1) , occupying the same genomic region for coding, sharing some exons, but probably having different Figure  1b ). In addition, mouse brain and human b-G share 5' region of exon 31 that is absent in elf-3. Similarly, elf-3 and human b-G share exon 23, 27 and 28 that are absent in mouse brain b-G. Exon 29 is absent in human b-G, and 3' region of exon 31 is present only in elf-3 ( Figure  1b,d) . Similarly, at the 5' site, the first exon utilized by elf-3 is not shared by b-G (Figure 1d ). Certainly, both human and mouse EST's support these alternatively spliced forms in both species. Interestingly, the human and mouse b-G/elf-3 vary in the 3' exons that are present in mouse, but absent in human. Human b-G/elf-3 variants therefore have a truncated 3' region ( Figure 1e ).
Characterization of the ELF promoter
The promoter sequence of elf/b-G bears one TATA box, and two transcription initiator sites ( Figure 1a) . The base composition analysis showed a somewhat high GC content of 56%, with 46 CpG dinucleotides in the upstream region of the elf gene. The ratio of CpG/ GpC is 47%. The potential regulatory sites are shown in Figure 1a . An Sp1 site is located at 7276 and 7271, but no further GC-boxes (GGGCGG) clustered further 5' (Kadonaga and Tjian, 1986) . Other GC-rich regulatory sequences such as AP-2 (GSSWGSSC; Roesler et al., 1989) and GCF (NNGCGGGGCN; Kageyama and Pastan, 1989) are scattered in the 5'-upstream regulatory region. The CTF/NF1 regulatory element involved in the expression of neural-specific genes is present in the region between 7396 and 7391 ( Figure 1a ). Recent studies have suggested that elf-3 is involved in TGF-b signaling, and further examination revealed seven Smad binding elements (CAGA/GTCT) were identified at 7504, 7529, 7546, 7870, 7981, 7991, 71026 ; AP-1 elements (TGANTMA) at 7578, 7592, 7687, 7972, 71041 (data not shown). The enhancer element RARE/TRE related to regulation of development is also present (Leid et al., 1992) .
Detection of ELF transcripts in adult human brain tissues
Northern blot analysis of adult human demonstrates an abundant 8 kb transcript in brain tissue ( Figure  1c ). ELF was expressed in all brain tissues, being most abundant in the thalamus, and brainstem structures, such as the substantia nigra and medulla. Relatively lower abundance of the elf 8 kb transcript is seen in the cerebral cortex, hippocampus, caudate nucleus and white matter. In addition, a less abundant 11 kb transcript, and even fainter 7.0, 4.4 and 3.2 kb transcripts are present in all tissues except for the amygdala and caudate nucleus. A detailed comparison of elf and b-G transcripts are described in Table 2 .
Anti-ELF antibody labels neuronal precursor cells
A polyclonal antibody, that recognizes the unique Nterminal sequence of ELF 3 (VA-1), , distinctly labels the cytoplasm, later axonal projections of cells in the marginal zone beginning at E9 and continuing through E14 (Figure 2a -f) . Confocal microscopy of sections double labeled with anti-ELF and anti-dystrophin confirms that anti-ELF labels neuronal precursors that are also labeled by dystrophin antibody (Figure 3g -l). In order to determine whether ELF was confined to neuronal cells and/or glial cells confocal microscopy on section double labeled by anti-ELF and anti-nestin, a neuronal precursor cell marker (Doetsch et al., 1997) , or antivimentin, a glial-precursor marker (Joosten and Gribnau, 1989) was performed. Double labeling confirms that anti-ELF and anti-nestin label the same cells and co-localize ( By E12 ELF label appears more restricted in the mantle zone of the forebrain with ELF label defining a single file of cells extending across the thickness of the cortical mantle, from the vesicular cavity to the outer surface of the developing brain (data not shown). In the E13 and E14 embryo, ELF label is seen as parallel fiber bundles arising out of scattered cells in the cortical mantle, directed towards the ventricular wall (Figure 2d -f). At these later stages a bipolar cytoplasmic labeling becomes apparent. Long filamentous pattern of labeling near one pole of the cell is combined with more amorphous clumping of ELF labeling in the opposite pole of the neuronal precursor cell-types ( Figure 2d ).
The most dramatic expression of ELF in the developing mouse brain is seen in the olfactory region in E12 embryo. Streaming ELF positive fibrillary bundles are seen extending from the roof of the developing nasal cavity into the prosencephalon in sagittal section (Figure 4a -d) . The ELF positive bundles start as a fan-shaped structure in the roof of the nasal cavity funneling through a narrow septum to cross into the prosencephalon before fanning out again (Figure 4a, b) . Under higher magnification, these ELF positive fibrillary processes from the roof of the nasal cavity appear to end into cells in the outer layer of the anterior end of the prosencephalon ( Figure  4b ,c). Anti-ELF labeled fibrillary structures in these 
ELF localization in the developing cerebellum
The outer layer of the developing cerebellum shows strong ELF reactivity at E12 (Figure 5a -f) . Again the label takes the form of long fibrillary processes directed towards the developing medullary zone of the cerebellum. Although most of the fibers extend a short distance, appearing as a curtain of labeled fibers falling towards the cerebellar medulla from the outer layer, a few fibrillary ELF positive processes are seen in the medullary region (Figure 5b -d) . The precursor cells from which the processes arise lie in the superficial layer of the cerebellum and a second group lies in the medullary zone. The cell bodies of these precursor cells are not labeled by anti-ELF. In contrast, ELF label appears in the dendritic processes extending from the 
ELF and ankyrin B expression
Confirming prior studies, we also found anti-ankyrin B labeling neuronal cells with specific localization in axons. At E13-14, anti-ankyrin B strongly labeled the spinal cord and dorsal root ganglion in our mouse sections. In addition a general weak staining was seen to be localized in cell bodies and dendrites, as previously seen by others. Labeling was also observed in the cortical subplate and the intermediate cortical layer of frontal cortex (data not shown).
ELF co-localizes with dystrophin
Labeling of both ELF and dystrophin occurs in vascular smooth muscle cells and cerebral cortical neurons (Figure 3g -l) . ELF, similarly to mouse dystrophin, is predominantly expressed in the neurons of the developing cerebral (Figure 3g -l) and cerebellar (Figure 5b -d) cortices. However, unlike dystrophin, the thalamus, and diencephalic structures contain the most ELF (Figure 1c ). In the cerebellar cell precursors, anti-ELF is seen in a linear filamentous pattern, while anti-dystrophin labeling is noted in an amorphous intracytoplasmic pattern in the soma and dendrites (data not shown). All of the cells that stained for dystrophin had a recognizable dendritic architecture and appeared to be of the stellate or fusiform type (data not shown). A subset of cells in the molecular layer labeled strongly for both ELF and dystrophin (Figure 3g -l) .
Glial cells and the white matter were non-reactive, for dystrophin. Little immunoreactivity was noted in other gray matter structures such as the diencephalon. In contrast, ELF expression is seen to be in a filamentous intracytoplasmic pattern in these tissues. Labeling was also seen in neuronal cell processes that include axons and dendrites (Figures 2, 4, 5) .
Discussion
Is Elf-3 a novel gene or an alternatively spliced isoform of b-G spectrin?
Analysis of genomic DNA sequence of elf revealed that elf is a 31 exon gene with exon/intron boundaries Earlier partial genomic sequence of b-G indicated alternate splicing (BG Forget, personal communication). We sought to obtain further genomic structural information to clarify whether elf exists as a separate discrete gene. Sequence analysis of the 67 Kb region spanning elf revealed the use of multiple common exons, with extended sequencing of the remote downstream region of elf showing further homologous sequence to b-G spectrin. Of note, while elf cDNA and b-G spectrin occupy the same coding region and share some exons, they utilize separate and distinct exons, as for example 5' region of exon 31 absent in elf while exon 1 and 3' region of exon 31 are present only in elf. These considerations combined with the distinct NH2-terminal amino acid sequences for ELF and mouse brain b-G, suggest the possibility of two classes of b-G spectrin transcripts, each with distinct promoter elements. Similar studies have been shown for human ankyrin-1 (ANK-1) and Ankyrin G , spectrin binding proteins, transcripts of the latter being selectively expressed in brain and kidney (Gallagher et al., 1997 (Gallagher et al., , 1999 Zhou et al., 1998) . A multitude of factors are responsible for diverse functions of spectrins. It is thus possible that the multiple isoforms of b-G spectrin are important at different developmental stages. However, evidence from recently generated null-mutants of elf confirms that elf is a novel b-G spectrin and not an isoform of previously described b-spectrins. Absence of elf DNA, mRNA, and protein in all mutant tissues analysed by Southern, RNA and protein blots demonstrates absence of a single DNA, RNA and protein family with no cross-reaction (manuscript in preparation).
ELF expression in developing mouse brain tissues
These studies suggest that elf3, a novel b-spectrin, is important for brain development from an early stage. Its striking localization to the axon hillock and axonal projection is consistent with its known involvement in axonal guidance as well as cell polarization (Moorthy et al., 2000; Hammarlund et al., 2000; Dubreuil et al., 2000) . ELF also appears to be a marker of purkinje cell precursors in the cerebellum. Spectrin also has been proposed to participate in the establishment of membrane subdomains in striated muscle (Craig and Pardo, 1983; Bloch and Morrow, 1989) , in lymphocyte capping (Black et al., 1988) , and in maintaining Golgi function and vesicular transport Devarajan et al., 1997; Fath et al., 1997; Stankewich et al., 1998; Beck and Nelson, 1998) . ELF could play a direct role in these processes of brain development through its involvement in cytoskeletal architecture, based on the appearance of the labeled cells. These observations are supported by the fact that spectrin comprises approximately 2.4% of total structural protein in mammalian brain homogenates (Davis and Bennett, 1983 ) is involved in the organization of presynaptic vesicles (Sikorski et al., 1991 (Sikorski et al., , 2000 , as well as in axonal transport (Levine and Willard, 1981).
ELF and spectrins
Developmental expression of bR-(erythroid) and bG-(nonerythroid) spectrin demonstrate bR-spectrin localizing to the cell body and dendrites, and bG-spectrin, to axons and presynaptic terminal Siman et al., 1987) . Interestingly, the Nterminal-ELF specific antibody labeled both cell bodies as well as dendrites and initial axon segments, and in this sense is unique in its expression pattern from spectrin G and Brain spectrin (Goodman et al., 1995) . Spectrin G is present in axons, and to a lesser extent, in neuronal cell bodies but not in dendrites , while ELF is expressed in both cell types. Brain spectrin (bR), an alternatively spliced form of erythrocyte spectrin is localized to the perikaryon, dendrites (like ELF/bG) and also glial precursor cells. The multiple gene products with restricted spatial and temporal expression indicates a more specialized function for these proteins. It is interesting to note that expression pattern of ELF is more similar to bR and the brain isoform of bG which is in keeping with its cDNA structure .
ELF and ankyrins
Two alternatively spliced isoforms of brain ankyrin, 440-and 220-kDa ankyrin B, have been studied in developing rat nervous system (Kunimoto et al., 1998) . Both isoforms appeared in rat fetus as early as E12-13. The 220-kDa ankyrin B was expressed mainly in neuronal precursor cells like ELF at a low level throughout prenatal period, being a major isoform before E14. The 440-kDa ankyrin B was detectable after E13 in several regions, including spinal cord, dorsal root ganglion, cortical subplate. In our study, ankyrin B was localized more in dendrites and cell bodies than on axons of primary cerebellar neurons. In support of this are recent studies of ankyrin B mutants that exhibit hypoplasia of the corpus callosum and pyramidal tracts, dilated ventricles, extensive degeneration of the optic nerve, and die by postnatal day 21 (Scotland et al., 1998) . Ankyrin G is required for clustering sodium channel (Nach) (Srinivasan et al., 1992) and neurofascin at axon initial segments and for physiological levels of voltage gated sodium channel activity Zhou et al., 1998) . Similarly to ELF, ankyrin G is confined to initial segments of axons of granule cells as well as purkinje neurons. Neurofascin and 270/ 480 ankyrin G are colocalized at axon initial segment in the neonatal cerebral cortex and not expressed in premyelinated axon tracts, corpus callosum and optic nerve. Mutant mice deficient of the brain isoform of ankyrin G suffered from progressive cerebellar ataxia in postnatal day 16 with loss of purkinje neurons.
The temporal expression of ankyrin genes in the rat brain parallels that of its preferred spectrin partner. Ankyrin R, like bR-spectrin, is expressed later in neuronal development. The expression of ELF, ankyrin R and bR-spectrin cells of the granular layer suggests that their expression may be coupled to the terminal stage of neuronal differentiation (Kordeli et al., 1990 (Kordeli et al., , 1995 . For ELF by day 12 or 13 staining around the cell body of Purkinje cells was strong but more prominent label was seen in the processes of the cerebellum shown. Staining was still present in ELF in cells of the proliferative zone or cells undergoing apparent migration. In contrast to ankyrin R, the ELF-spectrin antibody did not appear to stain the molecular layer of the cerebellum. The postmitotic expression of ELF, ankyrin R and bR-spectrin suggests that these proteins are involved in membrane remodeling consistent with a role in the formation of specialized membrane domains unique to the maturation stage of this subset of neurons.
ELF and dystrophin
Dystrophin is found in the postsynaptic neuronal membrane. Both ELF and dystrophin are present in neurons of the cerebellar and cerebral cortices, being restricted both in terms of cell type and subcellular localization (Lidov et al., 1990; Jung et al., 1991) . bspectrins and dystrophin are structurally related, providing neuronal support and regulating the distribution of integral membrane proteins (Lidov et al., 1990; Thomas, 2000) . The cerebellum is involved in generating smooth coordinated movements and a defect in this region may result in ataxia or tremormild symptoms of which are noted in older mdx mice mutant for the muscular dystrophy gene (12 months) (Bulfield et al., 1984) . Involvement of the cerebral cortex by dystrophin is consistent with moderate impairment of cognitive function is noted in Duchenne muscular dystrophy (Duchenne, 1872; Emery, 1988; Dubowitz and Crome, 1969) . Similarly, ELF may be linked to the defects seen in this disorder by virtue of its association with dystrophin.
ELF and nestin
An extremely interesting finding from this study is ELF colocalization with nestin in a similar subset of neurons to those described above. Nestin is a neurofilament protein expressed in neuronal precursor cells, and is also expressed in radial glial cells (Dahlstrand et al., 1995) , as well as in neurites and growth cones of primary cerebellar granule cells, supportive of its role in growth cone guidance during axon elongation. Our studies on ELF also support recent evidence that bspectrin is essential in growth cones for axon outgrowth, where it has been disrupted in C. elegans (Moorthy et al., 2000; Hammarlund et al., 2000) . Mutant animals appeared to have the normal complement of neurons, yet these neurons did not extend axons to their targets (Sobue and Kanda, 1989; Sobue, 1990) .
Direct evaluation of the functions of spectrins in non erythroid cells has been approached by several methods (Hu et al., 1995; Mishra et al., 1999) . Microinjections of N-terminal domain specific anti-b-spectrin inhibits neurite extension in neuroblastoma cells (Sihag et al., 1996) . Similarly, microinjection of fibroblasts with antibodies against spectrins resulted in the formation of spectrin aggregates, and the condensation of filaments. Expression of functional domains with b-G spectrin in cultured epithelial cells (CACO cells) resulted in loss of endogenous b-spectrin activity and loss of epithelial cell morphology, the cells becoming multinucleated and eventually disappeared after 10 -14 days in culture. Additionally spectrin associated membrane proteins such as ankyrin, adducin, the Na, 9.0 200 Brain, heart, kidney, Olfactory bulb axons; Fodrin and Ankyrin G/B skeletal muscle purkinje cell axons; associates with Ankyrin stellate cell dendrites; B; anti-sense disrupts developing cortex liver development b Spectrin ELF 4 7.5 240 Heart, skeletal muscle (Hayes et al., 2000) M&Z line, neutrites of Associates with fodaxin cerebellar granule cells 7.0 270 cell bodies of cerebellar granule cell neurons, forebrain, heart, skeletal, muscle and z line, postsynaptic dendrites Non-erythroid b spectrin 9.5 240 Lung (Chen et al., 2001) 7.5 225 Brain, lung, kidney, Associates with Schwannomin cerebellar neurons, Purkinje neurons (not dendrites,) trace-liver: K-ATPase are distributed abnormally reflecting a loss of cell polarity (Nelson and Veshnock, 1987b; Nelson and Hammerton, 1989; Hu et al., 1995) . In addition, utilizing antisense oligonucleotides to membrane ELF we have found inhibition of biliary epithelial cell formation in explant cultures .
Further genetic studies examining spectrin ablation have provided a number of novel in-sights into abspectrin assembly. For instance b-spectrin is essential in Drosophila: mutations resulting in lethality early in development (Dubreuil et al., 2000) . In these mutants, basolateral distribution of the Na,K ATPase in Drosophila larval copper cells was found to be dependent upon b-spectrin function, not aspectrin, giving rise to new information on spectrin function and binding partners. Spectrin binding to the NMDA receptor could lead to insights into its role in long term potentiation (Wechsler and Teichberg, 1998) . In addition, an abnormality in synaptic organization may account for the moderate cognitive impairment in muscular dystrophy (MarinPadilla, 1985; Takashima et al., 1981) . In sum the identification of ELF, and co-localization with dystrophin and nestin at neural precursor cells and cerebral cortical synapses could lead to mechanistic models for their involvement in defects in cognitive impairment.
Materials and methods
A 129SVEV mouse genomic DNA library in l-FIX-II vector was screened using the Z-2 probe for ELF by standard plaque hybridization method (Sambrook et al., 1989) . Briefly, duplicate filters were lifted, baked under vacuum at 808C for 1 h, and washed with 56SSC for 30 min. The filter was prehybridized at 608C with an improved Church & Gilbert solution (7% SDS, 1% BSA, 1 mM EDTA, pH 8.0, 500 mM, PO 4 buffer (134 g Na 2 HPO 4 8H 2 O, 4 ml phosphoric acid, pH 7.2, add H 2 O to 1L)) for 4 h followed by hybridization in the same solution with a random primed labeled (10 7 c.p.m./ml) cDNA probe, 3'UTR of elf. Hybridization was carried out at 608C for 17 h, and the filter was washed with 16SSC, 0.1% SDS at the same temperature. Positive plaques from duplicate filters were subjected to secondary and tertiary screening. At the same time, a mouse and human BAC library (Genome Systems) was screened and two BAC clones obtained, with sequence analysis being performed for three contigs, spanning about 67 kb of DNA.
Restriction enzyme mapping
One positive genomic clone G1, containing a 15 kb insert was digested with NotI and subcloned into the SK Bluescript vector (Stratagene). Restriction enzyme mapping of the isolated genomic clone was performed by a modification of standard methods (Whittaker and Southern, 1986) . Briefly, plasmid DNA from the clone G1 was dissolved in 100 ml of 16TE buffer (Digene). One mg of the plasmid DNA was used for each appropriate enzyme digestion. The sample was heated at 658C for 15 min and run on a 0.8% agarose gel for Southern analysis. Hybridization was performed as described above.
Sequencing and sequence analysis
All subcloned fragments were sequenced in both orientations and on both strands using the Sanger dideoxy chain termination method (Sanger et al., 1977; Sambrook et al., 1989) . The NCBI non-redundant (nr) databases as of January 10, 1998 were searched using the BLASTP2 and BLASTN2 programs, which permit gapped alignments (Altschul and Gish, 1996; Altschul et al., 1997) , with default parameters and ELF protein or nucleotide sequences as queries . Multiple sequences were aligned using the FINDPATTERNS (GCG version 9.1, Wisconsin package).
Northern blot analysis
Northern blots, containing 2 mg poly-A(+) mRNA from human brain (Clontech, USA), were probed with 32 P-labeled Elf Clone Z-2 (Mishra et al., 1997) insert antisense strand using ExpressHyb hybridization solution (Clontech, USA) at 688C. They were washed according to manufacturer's instructions and subjected to autoradiography. A 32 P-labeled b-actin probe supplied with the Northern blots was used as a control to confirm that normalized RNA levels were present in each lane (Clontech; data not shown).
Embryonic tissue preparation
Harlan ICR and 129SVEV/Black Swiss Mice were used. The age of the embryos was determined by day post-appearance of the vaginal plug (day 0). The noon of this day was considered 0.5 days of gestation post-coitus (p.c.). The embryos were dissected at transitional times between days of 9.5 and 14.5 p.c. The identification and isolation of embryos were carried out under an operative microscope. The specimens were fixed in FEA fixative (4% formaldehyde, 85% ethanol and 5% glacial acetic acid) and embedded in paraffin. The sections, 8 -15 mm thick, were cut in the longitudinal or transverse planes using a microtome (Reichert-Jung, USA).
Immunohistochemical staining
An indirect immunoperoxidase procedure was used for immunohistochemical localization of ELF protein in developing mouse nervous system (Blakeslee, 1977) . Serial, 8 mm thick sagittal sections of mouse embryos at different stages post coitus (E9.5, 10, 11, 12, 13, 14 p.c.) were immersed in Xylene to remove paraffin, then dehydrated in graded alcohol, and rinsed in 16PBS. Endogenous peroxide was quenched using 3% hydroten peroxide (Sigma). Non-specific binding sites were blocked using 1 ml PBS containing 5% goat serum and 1 mg/ml BSA. The sections were incubated overnight at 48C in a humidor with rabbit anti-ELF primary antibody diluted to 2.5 -5 mg/ml in 16PBS containing 1 mg/ ml BSA. All further steps were done at room temperature. Four 5-min rinses with 16PBS followed each successive step. The sections were then incubated with peroxidase-conjugated goat anti-rabbit antibody (Jackson Immunoresearch Laboratories, USA) that was diluted in 16PBS containing 1% goat serum, for 30 min at room temperature. After rinses, 200 -500 ml of the insoluble peroxidase substrate DAB (Sigma) was added to cover the entire tissue on the slide, and color development was monitored under the microscope. After rinsing in distilled water for 2 min, counterstaining was performed with modified Harris hematoxylin (Sigma) for 1 min followed by a rinse in distilled water for 3 min. Sections were dehydrated by passage through graded alcohol Elf, nestin and dystrophin in brain Y Tang et al concentrations and finally Xylene. Cover slips were mounted using DPX (Fluka Labs) before observation. PBS-serum only was used for negative controls.
Confocal laser-scanning immunofluorescence microscopy
Monoclonal mouse and rabbit polyclonal primary antibodies were visualized with Tetramethyl rhodamine isothiocyanate (TRITC)-conjugated goat anti-rabbit immunoglobulin G or Fluorescein isothiocyanate (FITC)-conjugated goat antimouse immunoglobulin G. The samples were analysed with a Bio-Rad MRC-600 confocal microscope (Bio-Rad, Cambridge, MA, USA), with an ILT model 5470K laser (Ion Laser Technology, Salt Lake City, UT, USA) as the source for the crypton -argo ion laser beam. FITC-stained samples were imaged by excitation at 488 nm and with a 505 to 540 bandpass emission filter, and Rhodamine-stained samples were imaged by excitation at 568 nm with a 598 -621 bandpass emission filter using a 606(numerical aperture 1.3) objective. Neuronal cells, developing astrocytes were identified by labeling with anti-nestin (Hybridoma Bank, Iowa, USA), vimentin (Santa Cruz), ankyrin B (kind gift from Dr V Bennett, Zymed), ankyrin G (Zymed) and dystrophin (Santa Cruz) antibodies. Co-localization properties of ELF with anti-vimentin, dystrophin and nestin were studied. Digital images were analysed using metamorph (Universal Imaging) and figures were prepared using Adobe Photoshop.
